"Parkland Health Center provides quality primary and secondary level inpatient and outpatient services to the people of St. Francois County and surrounding areas in southeastern Missouri."

During the past decade, Parkland Health Center-Bonne Terre conducted 122 clinical trials. In the 10-year time frame, 122 clinical trials started and 69 clinical trials were completed, i.e. on average, 56.6% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 61 clinical trials were completed. i.e. 217.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parkland Health Center-Bonne Terre" #1 sponsor was "National Cancer Institute (NCI)" with 80 trials, followed by "SWOG Cancer Research Network" with 32 trials sponsored, "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored and "Gynecologic Oncology Group" with 13 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parkland Health Center-Bonne Terre" #1 collaborator was "National Cancer Institute (NCI)" with 85 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Parkland Health Center-Bonne Terre" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Breast Carcinoma" (6 trials), "Recurrent Ovarian Carcinoma" (6 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (6 trials). Many other conditions were trialed in "Parkland Health Center-Bonne Terre" in a lesser frequency.

Most popular intervention types in "Parkland Health Center-Bonne Terre" are "Drug" (130 trials), "Other" (111 trials), "Biological" (64 trials), "Procedure" (45 trials) and "Radiation" (21 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (59 trials), "Quality-of-Life Assessment" (41 trials), "Computed Tomography" (24 trials), "Cisplatin" (23 trials) and "Biospecimen Collection" (21 trials). Other intervention names were less common.

The vast majority of trials in "Parkland Health Center-Bonne Terre" are 139 trials for "All" genders, 26 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Parkland Health Center-Bonne Terre". undefined are not yet recruiting, 33 are recruiting, 92 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Parkland Health Center-Bonne Terre, 3 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Parkland Health Center-Bonne Terre, 10 "Phase 1" clinical trials were conducted, 85 "Phase 2" clinical trials and 81 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".